Can a salt substitute help kidney patients? small study aims to find out

NCT ID NCT05558267

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study will test whether a potassium-containing salt substitute is safe for people with end-stage kidney disease on hemodialysis. Twenty participants will use the salt substitute for 16 days and regular table salt for 16 days, with a break in between. Researchers will measure potassium levels and watch for side effects like dangerously high potassium.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
potassium-containing salt substitute (Morton Lite Salt)
What this could lead to
If successful, this could point toward a safer way for kidney dialysis patients to use salt without dangerously raising potassium levels.
What could go wrong
This is a very small pilot study with only 20 participants, so results may not apply to everyone. The salt substitute could cause dangerously high potassium (hyperkalemia) in some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NYU Langone Health

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.